アクセラレーティング・メディカル・パートナーシップ・統合失調症プログラムの参加者の臨床評価
Jean Addington1, Lu Liu1, Monica Chu1
1Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Schizophrenia bulletin open
|August 27, 2025
まとめ
薬剤パートナーシップ統合失調症 (AMP SCZ) プログラムは,臨床高リスク (CHR) の個人を特徴付け,コントロール群よりも重度の症状と機能不全があることを発見しました. これは精神病のリスクを超えて 重要な臨床的課題を強調しています
科学分野:
- 精神科
- 神経科学
- 臨床心理学
背景:
- 薬剤パートナーシップ統合失調症 (AMP SCZ) プログラムは,臨床的変数とバイオマーカーを特徴づけることを目的としています.
- 臨床高リスク (CHR) 参加者およびコミュニティ・コントロール (CC) の大きなコホートが含まれています.
研究 の 目的:
- AMP SCZプログラムの参加者の臨床的特徴をベースラインにします.
- 精神病のリスクが高い個人の臨床プロファイルと機能を理解する.
主な方法:
- 1642人のCHRと519人のCCを含むデータセットの分析
- リスクのある精神状態の総合評価 (CAARMS) を用いてCHR基準と弱まった精神症状 (APS) の評価.
- 否定的な症状,うつ,自殺念頭,薬物使用,社会的機能,患者によるアウトカムに関する測定値を含める.
主要な成果:
- CHRの参加者は,CCと比較して,すべての臨床測定においてより厳しい評価を示した.
- CHRの個人では,社会的機能と役割の低下が観察されました.
- APSの測定値と他の臨床的変数との間に軽微な関連性が見られた.
結論:
- CHR患者は精神病のリスクを超えて重要な臨床的課題を経験し,以前の研究を支持しています.
- CHR群の複雑さは,様々な臨床測定値の間の重要な関連によって強調されています.
- 将来の研究は縦断データとバイオマーカーの関係に焦点を当てます
関連する概念動画
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Schizophrenia
217
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
217
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
947
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
947
Psychological and Sociocultural Causes of Schizophrenia
185
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
185


